Integer Holdings Co. (NYSE:ITGR) Stake Reduced by GSA Capital Partners LLP

GSA Capital Partners LLP lowered its position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 58.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,101 shares of the medical equipment provider's stock after selling 11,173 shares during the period. GSA Capital Partners LLP's holdings in Integer were worth $1,053,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in ITGR. Contravisory Investment Management Inc. grew its position in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after buying an additional 80 shares in the last quarter. Quest Partners LLC grew its position in shares of Integer by 3,688.9% during the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock worth $39,000 after buying an additional 332 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock worth $43,000 after buying an additional 142 shares in the last quarter. Innealta Capital LLC acquired a new stake in shares of Integer during the second quarter worth approximately $110,000. Finally, Hancock Whitney Corp acquired a new stake in shares of Integer during the first quarter worth approximately $203,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Stock Performance

ITGR stock traded down $1.65 during mid-day trading on Friday, reaching $133.18. The company had a trading volume of 210,429 shares, compared to its average volume of 310,315. The company has a quick ratio of 2.09, a current ratio of 3.28 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $4.47 billion, a P/E ratio of 41.12, a P/E/G ratio of 1.98 and a beta of 1.09. Integer Holdings Co. has a one year low of $84.75 and a one year high of $140.91. The stock's 50-day simple moving average is $129.20 and its two-hundred day simple moving average is $122.59.

Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.07. The company had revenue of $431.42 million for the quarter, compared to analysts' expectations of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The firm's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the business posted $1.27 earnings per share. Research analysts anticipate that Integer Holdings Co. will post 5.33 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Truist Financial decreased their price objective on shares of Integer from $150.00 to $147.00 and set a "buy" rating for the company in a report on Friday, October 25th. Bank of America lifted their price objective on shares of Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. Citigroup lifted their price objective on shares of Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a report on Tuesday, October 1st. KeyCorp lifted their price objective on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a report on Tuesday, October 15th. Finally, Benchmark lifted their price objective on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a report on Monday, October 21st. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $139.75.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.